Anke Schlenska-Lange
Overview
Explore the profile of Anke Schlenska-Lange including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
12
Citations
984
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Stojanovic Guzvic N, Luke F, Treitschke S, Coluccio A, Hoffmann M, Feliciello G, et al.
Mol Oncol
. 2024 Oct;
PMID: 39367702
While cell-free liquid biopsy (cfLB) approaches provide simple and inexpensive disease monitoring, cell-based liquid biopsy (cLB) may enable additional molecular genetic assessment of systemic disease heterogeneity and preclinical model development....
2.
Kutsch N, Giza A, Robrecht S, Stumpf J, Federhen A, Stoltefuss A, et al.
Eur J Haematol
. 2024 May;
113(2):235-241.
PMID: 38693677
Long-term data of chronic lymphocytic leukemia (CLL) patients with favorable risk who were treated with fludarabine, cyclophosphamide, and rituximab (FCR) within clinical trials show good efficacy. We here report long-term...
3.
Diefenhardt M, Fleischmann M, Martin D, Hofheinz R, Piso P, Germer C, et al.
Radiother Oncol
. 2022 Dec;
179:109455.
PMID: 36572280
Background: Total neoadjuvant therapy (TNT) can enhance local tumor regression, but its survival benefits compared to intensified chemoradiotherapy (CRT) followed by adjuvant chemotherapy (CT) remain unclear. Methods: This is a...
4.
Diefenhardt M, Schlenska-Lange A, Kuhnt T, Kirste S, Piso P, Bechstein W, et al.
Cancers (Basel)
. 2022 Aug;
14(15).
PMID: 35954320
Background: Early efficacy outcome measures in rectal cancer after total neoadjuvant treatment are increasingly investigated. We examined the prognostic role of pathological complete response (pCR), tumor regression grading (TRG) and...
5.
Fokas E, Schlenska-Lange A, Polat B, Klautke G, Grabenbauer G, Fietkau R, et al.
JAMA Oncol
. 2021 Nov;
8(1):e215445.
PMID: 34792531
Importance: Total neoadjuvant therapy has been increasingly adopted for multimodal rectal cancer treatment. The optimal sequence of chemoradiotherapy (CRT) and chemotherapy needs to be established. Objective: To report the long-term...
6.
Hucker S, Fehlmann T, Werno C, Weidele K, Luke F, Schlenska-Lange A, et al.
Nat Commun
. 2021 Jul;
12(1):4316.
PMID: 34262050
Molecular single cell analyses provide insights into physiological and pathological processes. Here, in a stepwise approach, we first evaluate 19 protocols for single cell small RNA sequencing on MCF7 cells...
7.
Faehling M, Schumann C, Christopoulos P, Hoffknecht P, Alt J, Horn M, et al.
Data Brief
. 2020 Dec;
34:106556.
PMID: 33364266
Following the PACIFIC trial, durvalumab has been approved by the European Medicines Agency (EMA) for consolidation of locally advanced PD-L1-positive NSCLC after chemoradiotherapy (CRT). Patients were treated with durvalumab in...
8.
Faehling M, Schumann C, Christopoulos P, Hoffknecht P, Alt J, Horn M, et al.
Lung Cancer
. 2020 Oct;
150:114-122.
PMID: 33126091
Background: Following the PACIFIC trial, durvalumab has been approved by the European Medicines Agency (EMA) for consolidation of locally advanced PD-L1-positive NSCLC after chemoradiotherapy (CRT). Patients were treated with durvalumab...
9.
Fokas E, Allgauer M, Polat B, Klautke G, Grabenbauer G, Fietkau R, et al.
J Clin Oncol
. 2019 Jun;
37(34):3212-3222.
PMID: 31150315
Purpose: Total neoadjuvant therapy is a new paradigm for rectal cancer treatment. Optimal scheduling of preoperative chemoradiotherapy (CRT) and chemotherapy remains to be established. Patients And Methods: We conducted a...
10.
Rodel C, Graeven U, Fietkau R, Hohenberger W, Hothorn T, Arnold D, et al.
Lancet Oncol
. 2015 Jul;
16(8):979-89.
PMID: 26189067
Background: Preoperative chemoradiotherapy with infusional fluorouracil, total mesorectal excision surgery, and postoperative chemotherapy with fluorouracil was established by the German CAO/ARO/AIO-94 trial as a standard combined modality treatment for locally...